Overdose, relapse after buprenorphine discontinuation high

Overdose, relapse after buprenorphine discontinuation high

(HealthDay)—Buprenorphine treatment may be needed for several years after an opioid overdose to reduce the risk of overdose and other adverse events, according to a study published online Dec. 2 in The American Journal of Psychiatry.

Arthur Robin Williams, M.D., from the New York State Psychiatric Institute at the Columbia University Medical Center in New York City, and colleagues used the MarketScan multistate Medicaid claims database (2013 to 2017) to identify adults (18 to 64 years of age) who received buprenorphine continuously for ≥180 days. Outcomes were assessed by buprenorphine duration period (six to nine months, nine to 12 months, 12 to 15 months, and 15 to 18 months).

The researchers found that adverse events were common across all cohorts, and almost half of patients (42.1 to 49.9 percent) were seen in the emergency department at least once. Patients retained for 15 to 18 months (931 patients) had significantly lower odds of visits (odds ratio, 0.75), inpatient hospitalizations (odds ratio, 0.79), and filling opioid prescriptions (odds ratio, 0.67) in the six months following discontinuation, compared to patients retained on buprenorphine for six to nine months (4,126 patients). Across cohorts, approximately 5 percent of patients experienced one or more medically treated overdoses.

"Patients and families need guidance, , and better coordination of care to help facilitate long-term maintenance with buprenorphine for opioid use disorder," Williams said in a statement.

Explore further

Opioid overdose risk is high after medical treatment ends, study finds

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: American Journal of Psychiatry

Copyright © 2019 HealthDay. All rights reserved.

Citation: Overdose, relapse after buprenorphine discontinuation high (2019, December 26) retrieved 20 October 2020 from https://medicalxpress.com/news/2019-12-overdose-relapse-buprenorphine-discontinuation-high.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments